This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (175)
-
November 24, 2025 | Official Statement Pfizer, Novo Nordisk proposed scheduling order granted by Delaware judge
Sections: Antitrust, DealRisk®, and Mergers and Acquisitions
-
November 24, 2025 | Insight Pfizer tells Delaware court it's still mulling case against Novo Nordisk (update*)
...Pfizer told the Delaware Court of Chancery on Friday that it is considering whether to make amendments...
Sections: Antitrust, DealRisk®, and Mergers and Acquisitions
-
November 21, 2025 | Insight Meta settles shareholder privacy case in US for $190m
...Court of Chancery (see here) over the company’s fiduciary responsibility to its investors in the wake...
Sections: Data Privacy and Security and Financial Crime
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login